John Vong - Nov 30, 2024 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Chief Accounting Officer
Signature
/s/ Kathy Diep, as Attorney-in-Fact
Stock symbol
ASTH
Transactions as of
Nov 30, 2024
Transactions value $
-$5,796
Form type
4
Date filed
12/3/2024, 04:15 PM
Previous filing
Nov 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Tax liability -$5.8K -134 -0.76% $43.25 17.5K Nov 30, 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.
F2 Includes 11,622 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 1,887 shares, of which 942 shares will vest on July 11, 2025 and 945 shares will vest on July 11, 2026; (ii) tranches of 380 shares and 380 shares, each of which will vest in two equal annual installments beginning on November 30, 2025; and (iii) tranches of 1,134 shares, 1,134 shares, 1,134 shares, 1,134 shares, and 4,439 shares, each of which will vest in five equal semi-annual installments beginning on May 12, 2025.
F3 Includes 76 shares acquired under the Issuer's Employee Stock Purchase Plan.